What are the indications of the COZING-IN01 home remedy for insomnia for elderly?
- Chronic headaches and migraine
- Feelings of worthlessness
- Loss of interest in activities and hobbies
- Irritability
- Long-term and unsubstantiated concerns
What's the technical parameter of the COZING-IN01?
|
Pulse modulation firequency range: |
OHIz-15Hz |
|
Pulse diation time: |
100ms ± 10ms |
|
Single pulse width: |
2ms 土0.4mS |
|
Pulse repetition frequcncy: |
250Hz±50Hz |
|
Lose out amplitude value: |
1.8土0.2V (5002) |
|
Built-in lithiun battery voltage: |
3.7 -4.2V |
|
The cboice of stirmulus time: |
15 minutes |
What are the advantages of the COZING-IN01 home remedy for insomnia for elderly?
CLealy LCD screen.
Connect the Earlobes to the main unit
CES for chronic headaches or insomnia.
Approved by EMA for over-the-counter treatment.
Increases serotonin levels through gentle, pulsed alternating current.
How does the home remedy for insomnia for elderly work?
The types of neurotransmitters that COZING-IN01 CES might stimulate include serotonin, melatonin, and norepinephrine.
Serotonin is a chemical that helps people feel happy, confident, or excited. It's called the 'feel-good hormone' for this reason. Melatonin aids in the body's sleep process and helps a person feel tired and fall asleep. Other neurotransmitters regulate our habits, pain response, and behavior.
A CES machine emits a very small amount of electricity, and the current is normally administered in a series of pulses. Most people don't even feel the pulses during their therapy. The effects are cumulative, which means you may not detect a difference in how you feel right away. Depending on their condition or symptoms, they have reported an improvement in as little as a day and as long as several weeks.
COZING-IN01 home remedy for insomnia for elderly Product Display:
COZING-IN01 home remedy for insomnia for elderly Clinical study:
Objective: Cranial electrotherapy stimulation (CES) emerges as a promising avenue for addressing insomnia concerns. Given the higher prevalence of insomnia among women, our investigation sought to assess CES's impact on enhancing sleep quality in young, healthy female individuals.
Methods: We conducted a meticulously designed randomized, controlled clinical trial involving 40 female participants aged between 18 to 35 years, devoid of any sleep-related disorders. Each participant underwent comprehensive polysomnography over two consecutive nights within a specialized sleep facility. During the second night, CES intervention was administered using the cutting-edge COZING-IN01 device, employing both active and sham stimulation modalities in a double-blinded fashion. Sleep metrics were meticulously scrutinized to discern variations between active and sham conditions, with additional focus on electroencephalogram (EEG) analysis to detect frequency alterations.
Results: Our comprehensive investigation yielded no discernible evidence of direct CES-induced alterations in sleep patterns utilizing the COZING-IN01 device. Post-CES application, we observed no significant disparities between the active and control (sham) groups. However, EEG spectral analysis did reveal a noteworthy decline in frequencies within the low-α frequency band (8-10 Hz).
Conclusions: While our findings suggest a potentially reproducible effect on α frequency modulation in EEG readings with CES application employing current levels exceeding 100 µA and likely frequencies surpassing 0.5 Hz, particularly when targeted directly at the cranium, no significant impact on conventional sleep parameters was noted. The observed influence on the low-α band, as evidenced in quantitative EEG analysis, underscores the necessity for further exploration in studies boasting adequate sample sizes to ascertain conclusive results.
FAQ
